Furthermore, among the 55 individuals on the sequencing panel that were diagnosed with T2D within 40 years of age and had their full clinical information to calculate their PTPs for testing positive for MODY, 17 participants (30.9%) had a PTP > 20%, suggesting their referral for genetic testing (Table 2). This evidence concerns the gene PTS and MODY.